These recalls involve products that pose serious risks of injury or death. Check if you own any of these products and take immediate action if needed.
1,488 critical product recalls that require immediate attention. These products have been identified as posing serious safety hazards.
Philips Medical Systems recalled 501 Allura Xper FD20 Biplane systems on September 3, 2025. The BIOS battery may deplete quickly, halting system startup without warning. The recall affects devices distributed worldwide, including the US and several countries in Europe and Asia.
Philips Medical Systems recalled 298 Allura Xper FD20 operating room tables on September 3, 2025, due to a faulty BIOS battery. The battery depletes faster than expected, halting system start-up without warning. This recall affects 72 units in the U.S. and 226 units distributed internationally.
Glenmark Pharmaceuticals recalled 26,928 packs of Viorele oral contraceptives on September 3, 2025. The recall follows the discovery of impurity issues in the product. Consumers should stop using the affected tablets immediately and contact healthcare providers for guidance.
Philips Medical Systems recalled 2,317 Allura Xper FD10 systems on September 3, 2025. The BIOS battery may deplete faster than expected, halting the system startup. Affected models include 722003, 722010, and 722026.
New Spirit Naturals recalled 178 units of Super Muscle Support Powder on September 3, 2025. The product contains an undeclared allergen, milk, posing a serious health risk. Consumers should stop using the product immediately and contact the company for a refund.
Philips Medical Systems recalled 585 Allura Xper FD10/10 imaging systems on September 3, 2025. The BIOS battery may deplete faster than expected, halting system start-up. This affects models 722005, 722011, and 722027 distributed worldwide.
Cardinal Health recalled Sulfamethoxazole and Trimethoprim tablets on September 2, 2025, due to contamination risks. A specific lot contained a foreign substance with a detected micro-organism, although no contamination was found on the tablets. Consumers must stop using the product immediately and seek guidance from healthcare providers.
Major Pharmaceuticals recalled Sulfamethoxazole and Trimethoprim tablets on September 2, 2025, due to contamination concerns. A foreign substance was found in the packaging material, although the tablets themselves remain unaffected. Consumers should stop using the product immediately and consult healthcare providers.
LeMaitre Vascular recalled 28 units of Artegraft Collagen Vascular Grafts on September 2, 2025. The recall affects multiple model numbers due to unapproved sourcing of raw materials. Patients and healthcare providers must stop using the device immediately and follow recall instructions.
Canon Medical System recalled eight digital radiography systems on September 2, 2025. The software issue may leave X-ray areas partially covered by static images. Users should stop using the device immediately and follow recall instructions.
AvKARE recalled 2,192 cartons of Norgestimate and Ethinyl Estradiol Tablets on September 2, 2025. The tablets failed content uniformity specifications, posing a high hazard risk. Consumers should stop using the product immediately and consult their healthcare provider.
I C F Factory recalled Vanilla G. Nutt Ice Cream on August 29, 2025, due to undeclared almonds. The recall affects 12 pints distributed in New York. Consumers should not consume the product and should seek a refund.
BigTree Sales Inc. recalled a handheld ultraviolet-C germicidal wand on August 29, 2025, due to unsafe levels of UVC radiation. The product can cause skin and eye injuries to users and nearby individuals. Consumers must stop using the device immediately and follow the manufacturer's instructions.
Fagron Compounding Services recalled 109,320 syringes of bevacizumab (Avastin) on August 29, 2025. The recall follows a lack of assurance of sterility, posing a high health risk. Consumers and healthcare providers should stop using the product immediately.
Baxter Healthcare recalled 136,512 IV sets on August 29, 2025, due to potential leaks. The recall affects products distributed nationwide across the United States. Patients and healthcare providers must stop using these devices immediately.
Baxter Healthcare recalled 12,720 CONTINU-FLO Solution Sets on August 29, 2025, due to a risk of leakage. The recall affects various states across the U.S. Healthcare providers and patients must stop using the product immediately.
Baxter Healthcare recalled 18,720 IV solution sets on August 29, 2025, due to a leak hazard. The recall affects devices distributed across the United States, including all 50 states. Patients and healthcare providers should stop using these devices immediately.
Baxter Healthcare recalled 15,552 IV extension sets on August 29, 2025, due to a leak risk. The recall affects products distributed nationwide across 50 states. Healthcare providers and patients must stop using the devices immediately.
Baxter Healthcare recalled 69,936 IV extension sets on August 29, 2025, due to a risk of leaking. The recall affects products with the code 2H8603 distributed nationwide. Patients and healthcare providers must stop using these devices immediately.
Baxter Healthcare recalled 106,176 units of the CLEARLINK SYSTEM CONTINU-FLO Solution Set on August 29, 2025. The recall follows reports that the IV sets may leak, posing a high risk to patients. Healthcare providers and patients must stop using the device immediately.